The Victoria Advocate

Alamar Biosciences launches the NULISAqpcr™ Custom Assay Development Kit to advance the development of novel biomarker assays for clinical research

FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the release of the ...
Business Wire

PhenoVista Biosciences Partners with NETRI to Expand Organ-on-Chip Service Offerings for Drug Development

SAN DIEGO--(BUSINESS WIRE)--PhenoVista Biosciences, a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay services based in San Diego, ...
News Medical

The Simoa® Accelerator Laboratory for biomarker testing and assay development

Ready to expand the possibilities of biomarker science? The Simoa® Accelerator Laboratory is a full-service center for biopharmaceutical research. The Accelerator Lab provides exploratory protein ...

Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay

Nautilus’ Iterative Mapping method enables single-molecule analysis of proteins and proteoforms and is designed to achieve comprehensive proteome coverage and detail at scale. The method empowers ...
Labroots

xPLOREing possibilities on the SMCxPRO™ platform: Development of an ultra-sensitive PK assay using custom assay services.

First in human (FIH) clinical trials of bispecific immunostimulatory antibodies commonly require a low starting dose based on a minimum anticipated biological effect level (MABEL) approach. To ...
News Medical

TaqPath assays and probes in biopharma

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...